Clearside Biomedical, Inc.CLSDNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-51.9%
5Y CAGR-30.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-51.9%/yr
Annual compound
5Y CAGR
-30.6%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 11.32% |
| 2023 | 3.64% |
| 2022 | -8693.75% |
| 2021 | 101.64% |
| 2020 | 51.25% |
| 2019 | 70.26% |
| 2018 | -15.45% |
| 2017 | -18.27% |
| 2016 | -36.81% |
| 2015 | -73.49% |